Claire Thomas
Direktor/Vorstandsmitglied bei REBUS HOLDINGS, INC.
Vermögen: - $ am 31.12.2023
Profil
Claire Thomas currently works at Rebus Holdings, Inc., as Independent Director from 2016 and Agensys, Inc., as Director.
Dr. Thomas also formerly worked at Millennium Pharmaceuticals, Inc., as Senior Vice President-Portfolio Management from 2008 to 2013 and Astellas Pharma, Inc., as Senior VP-Global Therapeutic & Head-Oncology from 2013 to 2016.
Dr. Thomas received her undergraduate degree and doctorate degree from the University of Illinois.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
REBUS HOLDINGS INC
0,00% | 15.03.2023 | 1 ( 0,00% ) | 0 $ | 31.12.2023 |
Aktive Positionen von Claire Thomas
| Unternehmen | Position | Beginn |
|---|---|---|
| REBUS HOLDINGS, INC. | Direktor/Vorstandsmitglied | 12.10.2016 |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Claire Thomas
| Unternehmen | Position | Ende |
|---|---|---|
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | 30.06.2016 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.2013 |
Ausbildung von Claire Thomas
| University of Illinois | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ASTELLAS PHARMA INC. | Health Technology |
| REBUS HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Commercial Services |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
